Provectus Announces Extension Of Rights Offering Due To Receipt Of Unsolicited Investment Proposals To Invest In Post author:Sam Post published:March 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's OncoMed Tanks Some More as GlaxoSmithKline Walks Away From R&D Pact July 10, 2017 AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017 Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017
AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017